1. |
[Comment] Continuous positive airway pressure is here to stay |
Atul Malhotra, Jeremy H Pettus |
|
2. |
[Comment] Re-evaluating the role of CPAP in OSA management amid obesity pharmacology advancements |
Neomi Shah |
|
3. |
[Viewpoint] Leveraging the pleural space for anticancer therapies in pleural mesothelioma |
Kevin G Blyth, Prasad S Adusumilli, Philippe Astoul, Liz Darlison, Y C Gary Lee, Aaron S Mansfield, Stefan J Marciniak, Nick Maskell, Vasiliki Panou, Tobias Peikert, Najib M Rahman, Marjorie G Zauderer, Daniel Sterman, Dean A Fennell |
|
4. |
[Articles] Extended pleurectomy decortication and chemotherapy versus chemotherapy alone for pleural mesothelioma (MARS 2): a phase 3 randomised controlled trial |
Eric Lim, David Waller, Kelvin Lau, Jeremy Steele, Anthony Pope, Clinton Ali, Rocco Bilancia, Manjusha Keni, Sanjay Popat, Mary O'Brien, Nadza Tokaca, Nick Maskell, Louise Stadon, Dean Fennell, Louise Nelson, John Edwards, Sara Tenconi, Laura Socci, Robert C Rintoul, Kelly Wood, Amanda Stone, Dakshinamoorthy Muthukumar, Charlotte Ingle, Paul Taylor, Laura Cove-Smith, Raffaele Califano, Yvonne Summers, Zacharias Tasigiannopoulos, Andrea Bille, Riyaz Shah, Elizabeth Fuller, Andrew Macnair, Jonathan Shamash, Talal Mansy, Richard Milton, Pek Koh, Andreea Alina Ionescu, Sarah Treece, Amy Roy, Gary Middleton, Alan Kirk, Rosie A Harris, Kate Ashton, Barbara Warnes, Emma Bridgeman, Katherine Joyce, Nicola Mills, Daisy Elliott, Nicola Farrar, Elizabeth Stokes, Vikki Hughes, Andrew G Nicholson, Chris A Rogers, MARS 2 Investigators |
|
5. |
[Comment] MARS 2 trial: the future of pleurectomy decortication in pleural mesothelioma |
Federica Grosso, Luigi Cerbone, Alessandra Curioni-Fontecedro |
|
6. |
[Articles] Effectiveness of preventive treatment among different age groups and Mycobacterium tuberculosis infection status: a systematic review and individual-participant data meta-analysis of contact tracing studies |
Leonardo Martinez, James A Seddon, C Robert Horsburgh, Christoph Lange, Anna M Mandalakas, TB Contact Studies Consortium |
|
7. |
[Comment] Overcoming barriers to scaling up tuberculosis preventive treatment for household contacts |
Gavin Churchyard, Nicole Salazar-Austin |
|
8. |
[Editorial] Tackling health disparities in asthma: a life-course challenge |
The Lancet Respiratory Medicine |
|
9. |
[Articles] Seralutinib in adults with pulmonary arterial hypertension (TORREY): a randomised, double-blind, placebo-controlled phase 2 trial |
Robert P Frantz, Vallerie V McLaughlin, Sandeep Sahay, Pilar Escribano Subías, Ronald L Zolty, Raymond L Benza, Richard N Channick, Kelly M Chin, Anna R Hemnes, Luke S Howard, Olivier Sitbon, Jean-Luc Vachiéry, Roham T Zamanian, Matt Cravets, Robert F Roscigno, David Mottola, Robin Osterhout, Jean-Marie Bruey, Erin Elman, Cindy-ann Tompkins, Ed Parsley, Richard Aranda, Lawrence S Zisman, Hossein-Ardeschir Ghofrani, TORREY Study Investigators |
|
10. |
[Comment] Treatment effects on functional outcomes in trials with severely ill patients |
Edmond S W Ng |
|
11. |
[Articles] Long-term outcomes after treatment of delirium during critical illness with antipsychotics (MIND-USA): a randomised, placebo-controlled, phase 3 trial |
Matthew F Mart, Leanne M Boehm, Amy L Kiehl, Michelle N Gong, Atul Malhotra, Robert L Owens, Babar A Khan, Margaret A Pisani, Gregory A Schmidt, R Duncan Hite, Matthew C Exline, Shannon S Carson, Catherine L Hough, Peter Rock, Ivor S Douglas, Daniel J Feinstein, Robert C Hyzy, William D Schweickert, David L Bowton, Andrew Masica, Onur M Orun, Rameela Raman, Brenda T Pun, Cayce Strength, Mark L Rolfsen, Pratik P Pandharipande, Nathan E Brummel, Christopher G Hughes, Mayur B Patel, Joanna L Stollings, E Wesley Ely, James C Jackson, Timothy D Girard |
|
12. |
[Articles] Azithromycin therapy for prevention of chronic lung disease of prematurity (AZTEC): a multicentre, double-blind, randomised, placebo-controlled trial |
John Lowe, David Gillespie, Ali Aboklaish, Tin Man Mandy Lau, Claudia Consoli, Malavika Babu, Mark Goddard, Kerenza Hood, Nigel Klein, Emma Thomas-Jones, Mark Turner, Marie Hubbard, Julian Marchesi, Janet Berrington, Sailesh Kotecha |
|
13. |
[Comment] Azithromycin for the prevention of chronic lung disease of prematurity: not a silver bullet |
Abdul Razak |
|
14. |
[News] US EPA confronts chemical plants’ deadly air pollution |
Bryant Furlow |
|
15. |
[Personal View] Chronic respiratory disease in Indigenous peoples: a framework to address inequity and strengthen respiratory health and health care globally |
Anne B Chang, Tom Kovesi, Gregory J Redding, Conroy Wong, Gonzalo G Alvarez, Rebecca Nantanda, Edgar Beltetón, Maynor Bravo-López, Maree Toombs, Paul J Torzillo, Diane M Gray |
|
16. |
[Comment] Vitamin A and bronchopulmonary dysplasia: the next steps |
Abhijeet Rakshasbhuvankar, J Jane Pillow |
|
17. |
[Articles] Early postnatal high-dose fat-soluble enteral vitamin A supplementation for moderate or severe bronchopulmonary dysplasia or death in extremely low birthweight infants (NeoVitaA): a multicentre, randomised, parallel-group, double-blind, placebo-controlled, investigator-initiated phase 3 trial |
Sascha Meyer, Johannes Bay, Axel R Franz, Harald Erhardt, Lars Klein, Jutta Petzinger, Christoph Binder, Susanne Kirschenhofer, Anja Stein, Britta Hüning, Axel Heep, Eva Cloppenburg, Julia Muyimbwa, Torsten Ott, Julia Sandkötter, Norbert Teig, Susanne Wiegand, Michael Schroth, Andrea Kick, Donald Wurm, Corinna Gebauer, Knud Linnemann, Jochen Kittel, Christian Wieg, Ursula Kiechl-Kohlendorfer, Susanne Schmidt, Ralf Böttger, Wolfgang Thomas, Francisco Brevis Nunez, Antje Stockmann, Thomas Kriebel, Andreas Müller, Daniel Klotz, Patrick Morhart, Donatus Nohr, Hans Konrad Biesalski, Eleni Z Giannopoulou, Susanne Hilt, Martin Poryo, Stefan Wagenpfeil, Nadja Haiden, Christian Ruckes, Anne Ehrlich, Ludwig Gortner, NeoVitaA trial investigators |
|
18. |
[News] New report outlines cost of inaction on AMR ahead of UN high-level meeting |
Talha Burki |
|
19. |
[Articles] Transbronchial cryobiopsy followed by as-needed surgical lung biopsy versus immediate surgical lung biopsy for diagnosing interstitial lung disease (the COLD study): a randomised controlled trial |
Kirsten A Kalverda, Maarten K Ninaber, Lizzy Wijmans, Jan von der Thüsen, René E Jonkers, Johannes M Daniels, Jelle R Miedema, Chris Dickhoff, Jürgen Hölters, David Heineman, Merijn Kant, Teodora Radonic, Ghada Shahin, Danielle Cohen, Bart Boerrigter, Suzan Nijman, Esther Nossent, Jerry Braun, Bas Mathot, Venerino Poletti, Jürgen Hetzel, Marcel Dijkgraaf, Daniel A Korevaar, Peter I Bonta, Jouke T Annema |
|
20. |
[Comment] Optimising the approach to ILD diagnosis: the balance of procedural complications against diagnostic accuracy |
Margaret L Salisbury, Kevin R Flaherty |
|
21. |
[News] European Lung Cancer Congress 2024 |
Priya Venkatesan |
|
22. |
[Comment] Realignment of clinical research after the COVID-19 era |
Dennis Thomas, Vanessa M McDonald, Peter G Gibson |
|
23. |
[Spotlight] A Monument to the Past |
Talha Burki |
|
24. |
[Articles] High-dose, short-duration versus standard rifampicin for tuberculosis preventive treatment: a partially blinded, three-arm, non-inferiority, randomised, controlled trial |
Rovina Ruslami, Federica Fregonese, Lika Apriani, Leila Barss, Nancy Bedingfield, Victor Chiang, Victoria J Cook, Dina Fisher, Eri Flores, Greg J Fox, James Johnston, Rachel K Lim, Richard Long, Catherine Paulsen, Thu Anh Nguyen, Nguyen Viet Nhung, Diana Gibson, Chantal Valiquette, Andrea Benedetti, Dick Menzies |
|
25. |
[Comment] High-dose rifampicin to treat tuberculosis infection: potential and pitfalls |
Theresa S Ryckman, Nicole Salazar-Austin |
|
26. |
[Articles] Efficacy of oral corticosteroids for acute preschool wheeze: a systematic review and individual participant data meta-analysis of randomised clinical trials |
Bohee Lee, Steve Turner, Meredith Borland, Péter Csonka, Jonathan Grigg, Theresa W Guilbert, Tuomas Jartti, Abraham Oommen, Jonathan Twynam-Perkins, Steff Lewis, Steve Cunningham |
|
27. |
[Comment] Oral corticosteroids for acute preschool wheeze |
Heidi Makrinioti |
|
28. |
[Comment] New framework to define the spectrum of tuberculosis |
Keertan Dheda, Giovanni Battista Migliori |
|
29. |
[Position Paper] Classification of early tuberculosis states to guide research for improved care and prevention: an international Delphi consensus exercise |
Anna K Coussens, Syed M A Zaidi, Brian W Allwood, Puneet K Dewan, Glenda Gray, Mikashmi Kohli, Tamara Kredo, Ben J Marais, Guy B Marks, Leo Martinez, Morten Ruhwald, Thomas J Scriba, James A Seddon, Phumeza Tisile, Digby F Warner, Robert J Wilkinson, Hanif Esmail, Rein M G J Houben, International Consensus for Early TB (ICE-TB) group |
|
30. |
[Comment] Systematic endoscopic staging of mediastinum in locally advanced NSCLC: a SEISMIC change? |
Angela Botticella, Antonin Levy, Cécile Le Pechoux |
|
31. |
[Articles] Systematic endoscopic staging of mediastinum to guide radiotherapy planning in patients with locally advanced non-small-cell lung cancer (SEISMIC): an international, multicentre, single-arm, clinical trial |
Daniel P Steinfort, Gargi Kothari, Neil Wallace, Nicholas Hardcastle, Kanishka Rangamuwa, Edith M T Dieleman, Percy Lee, Peixuan Li, Julie A Simpson, Shaun Yo, Farzad Bashirdazeh, Phan Nguyen, Barton R Jennings, David Fielding, Laurence Crombag, Louis B Irving, Kazuhiro Yasufuku, Jouke T Annema, David E Ost, Shankar Siva |
|